800-872-2273

Clinical Trials and Studies

Your participation matters. Help us discover and cure!

Contact us at (800) USC-CARE (800-872-2273)

We're sorry, but this trial is no longer enrolling volunteers.

Description

Phase

Phase 3/4

Inclusion and Exclusion Criteria

Please contact Jose Aparicio to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.

Sites

  • California

    • Novartis Investigative Site, Torrance, California, 90509
    • Novartis Investigative Site, Los Alamitos, California, 90720
    • Novartis Investigative Site, Oceanside, California, 92056
    • Novartis Investigative Site, La Jolla, California, 92037
    • Novartis Investigative Site, Fresno, California, 93710
    • Novartis Investigative Site, Berkeley, California, 94705
    • Novartis Investigative Site, San Francisco, California, 94117
    • Novartis Investigative Site, Sacramento, California, 95817

  • Nevada

    • Novartis Investigative Site, Las Vegas, Nevada, 89106

  • Arizona

    • Novartis Investigative Site, Sun City, Arizona, 85351
    • Novartis Investigative Site, Phoenix, Arizona, 85013
    • Novartis Investigative Site, Phoenix, Arizona, 85004
    • Novartis Investigative Site, Phoenix, Arizona, 85018
    • Novartis Investigative Site, Gilbert, Arizona, 85234
    • Novartis Investigative Site, Tucson, Arizona, 85741

  • Utah

    • Novartis Investigative Site, Salt Lake City, Utah, 84103

  • New Mexico

    • Novartis Investigative Site, Albuquerque, New Mexico, 87131

  • Colorado

    • Novartis Investigative Site, Colorado Springs, Colorado, 80920
    • Novartis Investigative Site, Boulder, Colorado, 80304
    • Novartis Investigative Site, Denver, Colorado, 80218
    • Novartis Investigative Site, Denver, Colorado, 80220
    • Novartis Investigative Site, Aurora, Colorado, 80045
    • Novartis Investigative Site, Fort Collins, Colorado, 80525
    • Novartis Investigative Site, Fort Collins, Colorado, 80528

  • Oregon

    • Novartis Investigative Site, Portloand, Oregon, 97225

  • Washington

    • Novartis Investigative Site, Issaquah, Washington, 98029
    • Novartis Investigative Site, Seattle, Washington, 98101

  • Montana

    • Novartis Investigative Site, Great Falls, Montana, 59405
    • Novartis Investigative Site, Great Falls, Montana, 59405

  • Oklahoma

    • Novartis Investigative Site, Oklahoma City, Oklahoma, 73112
    • Novartis Investigative Site, Oklahoma City, Oklahoma, 73104
    • Novartis Investigative Site, Oklahoma City, Oklahoma, 73104
    • Novartis Investigative Site, Tulsa, Oklahoma, 74137

  • Texas

    • Novartis Investigative Site, San Antonio, Texas, 78229
    • Novartis Investigative Site, San Antonio, Texas, 78231
    • Novartis Investigative Site, San Antonio, Texas, 78258
    • Novartis Investigative Site, Round Rock, Texas, 78681
    • Novartis Investigative Site, Sherman, Texas, 75092
    • Novartis Investigative Site, Dallas, Texas, 75246
    • Novartis Investigative Site, Dallas, Texas, 75390
    • Novartis Investigative Site, Dallas, Texas, 75214
    • Novartis Investigative Site, Houston, Texas, 77076
    • Novartis Investigative Site, Houston, Texas, 77030

  • Kansas

    • Novartis Investigative Site, Kansas City, Kansas, 66160
    • Novartis Investigative Site, Lenexa, Kansas, 66212

  • Missouri

    • Novartis Investigative Site, Kansas City, Missouri, 64111
    • Novartis Investigative Site, Saint Louis, Missouri, 63141
    • Novartis Investigative Site, St. Louis, Missouri, 63131
    • Novartis Investigative Site, St. Louis, Missouri, 63104

  • Iowa

    • Novartis Investigative Site, West Des Moines, Iowa, 50314

  • Arkansas

    • Novartis Investigative Site, Little Rock, Arkansas, 72205

  • Minnesota

    • Novartis Investigative Site, Golden Valley, Minnesota, 55422

  • Tennessee

    • Novartis Investigative Site, Cordova, Tennessee, 38018
    • Novartis Investigative Site, Nashville, Tennessee, 37205
    • Novartis Investigative Site, Nashville, Tennessee, 37204

  • Louisiana

    • Novartis Investigative Site, Hammond, Louisiana, 70403
    • Novartis Investigative Site, New Orleans, Louisiana, 70121

  • Illinois

    • Novartis Investigative Site, Elk Grove Village, Illinois, 60007
    • Novartis Investigative Site, Elk Grove Village, Illinois, 60007
    • Novartis Investigative Site, Palos Heights, Illinois, 60463
    • Novartis Investigative Site, Northbrook, Illinois, 60062
    • Novartis Investigative Site, Flossmoor, Illinois, 60422
    • Novartis Investigative Site, Chicago, Illinois, 60612
    • Novartis Investigative Site, Evanston, Illinois, 60201

  • Mississippi

    • Novartis Investigative Site, Ocean Springs, Mississippi, 39564

  • Wisconsin

    • Novartis Investigative Site, Milwaukee, Wisconsin, 53215

  • Alabama

    • Novartis Investigative Site, Cullman, Alabama, 35058
    • Novartis Investigative Site, Huntsville, Alabama, 35801

  • Indiana

    • Novartis Investigative Site, Indianapolis, Indiana, 46202
    • Novartis Investigative Site, Indianapolis, Indiana, 46256

  • Kentucky

    • Novartis Investigative Site, Louisville, Kentucky, 40207
    • Novartis Investigative Site, Lexington, Kentucky, 40536

  • Michigan

    • Novartis Investigative Site, Grand Rapids, Michigan, 49503

  • Ohio

    • Novartis Investigative Site, Cincinnati, Ohio, 45219
    • Novartis Investigative Site, Dayton, Ohio, 45408
    • Novartis Investigative Site, Dayton, Ohio, 45408

  • Georgia

    • Novartis Investigative Site, Douglasville, Georgia, 30134
    • Novartis Investigative Site, Douglasville, Georgia, 30134
    • Novartis Investigative Site, Atlanta, Georgia, 30327

  • Mexico

    • Novartis Investigative Site, Culiacan, 80020

  • San Luis Potosí

    • Novartis Investigative Site, San Luis Potosi, San Luis Potosí, 78240
Powered by SC CTSI